Joel Greenblatt’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.09M | Buy |
59,174
+6,342
| +12% | +$556K | 0.01% | 939 |
|
|
2026
Q1 | $4.78M | Buy |
+52,832
| New | +$4.85M | 0.01% | 877 |
|
|
2025
Q4 | – | Sell |
-39,377
| Closed | -$3.88M | – | 1829 |
|
|
2025
Q3 | $3.88M | Sell |
39,377
-49,592
| -56% | -$4.91M | 0.02% | 841 |
|
|
2025
Q2 | $8.11M | Buy |
88,969
+66,829
| +302% | +$6.46M | 0.05% | 531 |
|
|
2025
Q1 | $2.51M | Sell |
22,140
-28,687
| -56% | -$3.07M | 0.02% | 726 |
|
|
2024
Q4 | $5.37M | Buy |
50,827
+40,384
| +387% | +$4.33M | 0.05% | 495 |
|
|
2024
Q3 | $1.13M | Sell |
10,443
-58,608
| -85% | -$6.4M | 0.01% | 890 |
|
|
2024
Q2 | $7.49M | Buy |
69,051
+38,528
| +126% | +$4.54M | 0.1% | 295 |
|
|
2024
Q1 | $4.03M | Buy |
30,523
+7,017
| +30% | +$877K | 0.06% | 435 |
|
|
2023
Q4 | $2.86M | Sell |
23,506
-20,599
| -47% | -$2.3M | 0.05% | 478 |
|
|
2023
Q3 | $4.95M | Buy |
44,105
+706
| +2% | +$89.7K | 0.1% | 266 |
|
|
2023
Q2 | $6.32M | Sell |
43,399
-10,660
| -20% | -$1.45M | 0.14% | 164 |
|
|
2023
Q1 | $6.98M | Buy |
54,059
+48,230
| +827% | +$6.06M | 0.17% | 109 |
|
|
2022
Q4 | $743K | Sell |
5,829
-43,001
| -88% | -$4.99M | 0.02% | 776 |
|
|
2022
Q3 | $5.11M | Buy |
48,830
+1,662
| +4% | +$182K | 0.15% | 154 |
|
|
2022
Q2 | $4.96M | Buy |
+47,168
| New | +$5.6M | 0.16% | 153 |
|
|
2022
Q1 | – | Sell |
-15,360
| Closed | -$1.9M | – | 1261 |
|
|
2021
Q4 | $1.9M | Buy |
+15,360
| New | +$2.01M | 0.06% | 357 |
|
|
2021
Q2 | – | Sell |
-1,444
| Closed | -$224K | – | 1127 |
|
|
2021
Q1 | $224K | Sell |
1,444
-3,851
| -73% | -$597K | 0.01% | 922 |
|
|
2020
Q4 | $792K | Sell |
5,295
-1,993
| -27% | -$281K | 0.03% | 606 |
|
|
2020
Q3 | $963K | Sell |
7,288
-43,863
| -86% | -$5.73M | 0.03% | 549 |
|
|
2020
Q2 | $5.93M | Sell |
51,151
-1,943
| -4% | -$224K | 0.18% | 159 |
|
|
2020
Q1 | $5.21M | Buy |
+53,094
| New | +$6.96M | 0.14% | 214 |
|
|
2019
Q2 | – | Sell |
-78,481
| Closed | -$9.73M | – | 1306 |
|
|
2019
Q1 | $9.73M | Buy |
+78,481
| New | +$8.92M | 0.14% | 209 |
|
|
2018
Q3 | – | Sell |
-79,383
| Closed | -$8.59M | – | 1039 |
|
|
2018
Q2 | $8.59M | Buy |
+79,383
| New | +$8.64M | 0.12% | 241 |
|
|
2018
Q1 | – | Sell |
-315,984
| Closed | -$37M | – | 1093 |
|
|
2017
Q4 | $37M | Buy |
315,984
+154,719
| +96% | +$17.5M | 0.54% | 36 |
|
|
2017
Q3 | $18.3M | Buy |
161,265
+71,059
| +79% | +$8.2M | 0.27% | 109 |
|
|
2017
Q2 | $11.2M | Sell |
90,206
-78,988
| -47% | -$9.36M | 0.16% | 207 |
|
|
2017
Q1 | $20.1M | Buy |
169,194
+134,449
| +387% | +$15.2M | 0.25% | 118 |
|
|
2016
Q4 | $3.48M | Sell |
34,745
-130,934
| -79% | -$14M | 0.04% | 435 |
|
|
2016
Q3 | $20.9M | Sell |
165,679
-358,418
| -68% | -$44.3M | 0.27% | 119 |
|
|
2016
Q2 | $61.3M | Buy |
524,097
+372,168
| +245% | +$42.1M | 0.73% | 17 |
|
|
2016
Q1 | $15.7M | Buy |
+151,929
| New | +$14.7M | 0.18% | 193 |
|
|
2015
Q1 | – | Sell |
-3,796
| Closed | -$418K | – | 1039 |
|
|
2014
Q4 | $418K | Sell |
3,796
-755
| -17% | -$79.6K | ﹤0.01% | 762 |
|
|
2014
Q3 | $444K | Sell |
4,551
-219
| -5% | -$21.5K | ﹤0.01% | 783 |
|
|
2014
Q2 | $481K | Sell |
4,770
-42,195
| -90% | -$4.12M | 0.01% | 792 |
|
|
2014
Q1 | $4.31M | Buy |
46,965
+44,193
| +1,594% | +$4.07M | 0.06% | 389 |
|
|
2013
Q4 | $251K | Sell |
2,772
-2,945
| -52% | -$255K | 0.01% | 896 |
|
|
2013
Q3 | $456K | Sell |
5,717
-10,721
| -65% | -$844K | 0.01% | 702 |
|
|
2013
Q2 | $1.2M | Buy |
+16,438
| New | +$1.23M | 0.05% | 488 |
|
Other funds holding ZBH
Joel Greenblatt's ZBH Position: Q2 2026 in Review
Joel Greenblatt increased its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, buying an estimated $556K and bringing the position to 59,174 shares worth $5.09M. The position accounts for 0.01% of the portfolio, ranked #939.
Joel Greenblatt first reported a position in ZBH in Q2 2013 and has held it in 39 quarters since. The position peaked at $61.3M in Q2 2016. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Joel Greenblatt held 59,174 shares of Zimmer Biomet worth $5.09M as of Q2 2026.
- Joel Greenblatt bought 6,342 Zimmer Biomet shares in Q2 2026, an estimated $556K.
- Zimmer Biomet made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #939 holding.
- Joel Greenblatt first reported a position in Zimmer Biomet in Q2 2013 and has held it in 39 quarters since.
- Joel Greenblatt's Zimmer Biomet position peaked at $61.3M in Q2 2016.
- 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.